Stonepine Capital Management, LLC Ani Pharmaceuticals Inc Transaction History
Stonepine Capital Management, LLC
- $103 Billion
- Q1 2025
A detailed history of Stonepine Capital Management, LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Stonepine Capital Management, LLC holds 48,000 shares of ANIP stock, worth $3.18 Million. This represents 13.28% of its overall portfolio holdings.
Number of Shares
48,000
Previous 20,400
135.29%
Holding current value
$3.18 Million
Previous $1.13 Billion
1110.32%
% of portfolio
13.28%
Previous 0.91%
Shares
5 transactions
Others Institutions Holding ANIP
# of Institutions
239Shares Held
20.2MCall Options Held
7.4KPut Options Held
12.4K-
Black Rock Inc. New York, NY2.66MShares$176 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.18MShares$78.3 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny818KShares$54.2 Million0.03% of portfolio
-
Global Alpha Capital Management Ltd.736KShares$48.7 Million3.53% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il723KShares$47.9 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.15B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...